Ipratropium Bromide | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Ipratropium Bromide
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Ipratropium Bromide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 8 USDMF, 9 CEP/COS, 1 JDMF, 5 EU WC, 9 KDMF, 15 NDC API, 21 Listed Suppliers, $ API Reference Price

26 API Suppliers
8 USDMF
9 CEP/COS
1 JDMF
5 EU WC
9 KDMF
15 NDC API
21 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

183 FDF Dossiers, 42 FDA Orange Book, 81 Europe, 18 Canada, 5 Australia, 22 South Africa, 15 Listed Dossiers

183 FDF Dossiers
42 FDA Orange Book
81 Europe
18 Canada
5 Australia
22 South Africa
15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.042MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - 0.042MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

5 Actylis, 1 Finar

5 Actylis
1 Finar

EXCIPIENTS BY APPLICATIONS

4 Parenteral, 2 Solubilizers

4 Parenteral
2 Solubilizers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 15 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 56 Finished Drug Prices

1 US Medicaid Prescriptions
56 Finished Drug Prices

MARKET PLACE

10 APIs, 6 FDF Dossiers, 1 EXCIPIENTS

10 APIs
6 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

7 US Patents, 1 Health Canada Patents

7 US Patents
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 9 Others

4 EDQM
4 USP
9 Others

$ API Ref.Price (USD/KG) : 4,494 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Boehringer Ingelheim (Canada) Ltd.

filter Patent Reset all filters

1 All

01 12151383

filter Product Reset all filters

1 All

01 1Ipratropium Bromide

filter Dosage Reset all filters

1 All

01 1Metered-Dose (Aerosol)

filter Exp Date Reset all filters

1 All

01 12013-12-06

Vamsi labs Ipratropium Bromide

Product Main Page

01

Boehringer Ingelheim (Canada) Ltd.

Ipratropium Bromide

The Generic Rx Session

Not Confirmed

Boehringer Ingelheim (Canada) Ltd.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-06

Date Granted : 2005-02-08

Ipratropium Bromide

Brand Name : ATROVENT HFA

Patent Number : 2151383

Filing Date : 1993-12-06

Strength per Unit : 20 mcg/actuation

Dosage Form : Metered-Dose (Aerosol)

Human Or VET : Human

Route of Administration : Inhalation

Patent Expiration Date : 2013-12-06

Date Granted : 2005-02-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!